New ADA position statement stresses differences b/w pediatri
Type 1 diabetes management for children and adolescents must not be extrapolated from adult diabetes care, and providers should consider a child’s evolving developmental stages in creating an adaptive care plan to best suit his or her changing needs, according to a position statement released today by the American Diabetes Association.

In an update of the ADA’s original position statement published in 2005, the researchers emphasized the importance of adapting type 1 diabetes care to a child’s needs and circumstances, with an emphasis on timely guidance and care coordination to allow an eventual seamless transition from adolescence to young adulthood for both the child with type 1 diabetes and his or her family.

The statement highlights the importance of type 1 staging, proper screening and testing, blood glucose management, recommendations regarding adjunctive therapies and lifestyle management, as well as the management of complications and comorbidities in children.

Glucose management in children
• Most children with type 1 diabetes should be treated with an intensive insulin regimen via either multiple daily injection therapy of prandial and basal insulin or continuous insulin pump therapy

• Continuous glucose monitoring should be considered in all children and adolescents with type 1 diabetes regardless of insulin delivery method to help improve glycemic profile.

• Automated insulin delivery systems “appear to improve glycemic control” and reduce hypoglycemia in children and should be considered in pediatric patients with type 1 diabetes.

Read more here:

Original paper can be accessed here: